SUCNR1 and ovarian cancer: For example, T cell activation, interleukin signaling pathway, chemokine signaling pathway, antigen processing and presentation, natural killer cell mediated cytotoxicity, cancer immunotherapy by PD-1 blockade, adaptive immune system, and interferon alpha/beta signaling were closely associated with the expression of SUCNR1 in ovarian cancer (Figures 8C–F).